139 related articles for article (PubMed ID: 2974781)
1. NPH insulin administration by means of a pen injector.
Jørgensen JO; Flyvbjerg A; Jørgensen JT; Sørensen HH; Johansen BR; Christiansen JS
Diabet Med; 1988 Sep; 5(6):574-6. PubMed ID: 2974781
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of the efficacy and acceptability of a pen injector.
Murray DP; Keenan P; Gayer E; Salmon P; Tomkin GH; Drury MI; O'Sullivan DJ
Diabet Med; 1988 Nov; 5(8):750-4. PubMed ID: 2975567
[TBL] [Abstract][Full Text] [Related]
3. [Insuject-X for children. A clinical trial of the NPH insulin pen].
Rix M; Voght H; Nielsen K; Jakobsen G; Holsteen V
Ugeskr Laeger; 1990 Apr; 152(15):1086-9. PubMed ID: 2184557
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.
Lucidi P; Porcellati F; Marinelli Andreoli A; Carriero I; Candeloro P; Cioli P; Bolli GB; Fanelli CG
Diabetes Care; 2015 Dec; 38(12):2204-10. PubMed ID: 26358287
[TBL] [Abstract][Full Text] [Related]
5. Deterioration in blood glucose control in females with diabetes changed to a basal-bolus regimen using a pen-injector.
Hardy KJ; Jones KE; Gill GV
Diabet Med; 1991 Jan; 8(1):69-71. PubMed ID: 1826248
[TBL] [Abstract][Full Text] [Related]
6. Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin.
De Leeuw I; Vague P; Selam JL; Skeie S; Lang H; Draeger E; Elte JW
Diabetes Obes Metab; 2005 Jan; 7(1):73-82. PubMed ID: 15642078
[TBL] [Abstract][Full Text] [Related]
7. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.
Home PD; Rosskamp R; Forjanic-Klapproth J; Dressler A;
Diabetes Metab Res Rev; 2005; 21(6):545-53. PubMed ID: 16021649
[TBL] [Abstract][Full Text] [Related]
8. Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes.
Kølendorf K; Ross GP; Pavlic-Renar I; Perriello G; Philotheou A; Jendle J; Gall MA; Heller SR
Diabet Med; 2006 Jul; 23(7):729-35. PubMed ID: 16842476
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin.
Pieber TR; Draeger E; Kristensen A; Grill V
Diabet Med; 2005 Jul; 22(7):850-7. PubMed ID: 15975098
[TBL] [Abstract][Full Text] [Related]
10. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.
Murphy NP; Keane SM; Ong KK; Ford-Adams M; Edge JA; Acerini CL; Dunger DB
Diabetes Care; 2003 Mar; 26(3):799-804. PubMed ID: 12610040
[TBL] [Abstract][Full Text] [Related]
11. Twice-daily mixed regular and NPH insulin injections with new jet injector versus conventional syringes: pharmacokinetics of insulin absorption.
Hallé JP; Lambert J; Lindmayer I; Menassa K; Coutu F; Moghrabi A; Legendre L; Legault C; Lalumière G
Diabetes Care; 1986; 9(3):279-82. PubMed ID: 3525057
[TBL] [Abstract][Full Text] [Related]
12. Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections.
Colombel A; Murat A; Krempf M; Kuchly-Anton B; Charbonnel B
Diabet Med; 1999 Apr; 16(4):319-24. PubMed ID: 10220206
[TBL] [Abstract][Full Text] [Related]
13. The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes.
Standl E; Lang H; Roberts A
Diabetes Technol Ther; 2004 Oct; 6(5):579-88. PubMed ID: 15628811
[TBL] [Abstract][Full Text] [Related]
14. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
Clin Ther; 2004 May; 26(5):724-36. PubMed ID: 15220016
[TBL] [Abstract][Full Text] [Related]
15. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM.
Wolfsdorf JI; Laffel LM; Pasquarello C; Vernon A; Herskowitz RD
Diabetes Care; 1991 Nov; 14(11):1100-6. PubMed ID: 1797498
[TBL] [Abstract][Full Text] [Related]
16. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
17. Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.
Bolli GB; Songini M; Trovati M; Del Prato S; Ghirlanda G; Cordera R; Trevisan R; Riccardi G; Noacco C
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):571-9. PubMed ID: 18676131
[TBL] [Abstract][Full Text] [Related]
18. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
19. Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.
Chatterjee S; Jarvis-Kay J; Rengarajan T; Lawrence IG; McNally PG; Davies MJ
Diabetes Res Clin Pract; 2007 Aug; 77(2):215-22. PubMed ID: 17141354
[TBL] [Abstract][Full Text] [Related]
20. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
Fulcher GR; Gilbert RE; Yue DK
Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
